Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Estella-Hermoso-de-Mendoza, A. (Ander) | - |
dc.creator | Campanero, M.A. (Miguel Angel) | - |
dc.creator | Lana, H. (Hugo) | - |
dc.creator | Villa-Pulgarin, J.A. (Janny A.) | - |
dc.creator | Iglesia-Vicente, J. (Janis) de la | - |
dc.creator | Mollinedo, F. (Faustino) | - |
dc.creator | Blanco-Prieto, M.J. (María José) | - |
dc.date.accessioned | 2013-05-06T14:11:12Z | - |
dc.date.available | 2013-05-06T14:11:12Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Ander Estella-Hermoso de Mendoza, Miguel A Campanero, Hugo Lana, Janny A Villa-Pulgarin, Janis de la Iglesia-Vicente, Faustino Mollinedo, and María J Blanco-Prieto. Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles. Nanomedicine, May 2012, Vol. 7, No. 5 , Pages 679-690 | es_ES |
dc.identifier.issn | 1743-5889 | - |
dc.identifier.uri | https://hdl.handle.net/10171/29159 | - |
dc.description.abstract | Lipid nanoparticles (LN) made of synthetic lipids Compritol® 888 ATO and Precirol® ATO 5 were developed, presenting an average size of 110.4 ± 2.1 nm and 103.1 ± 2.9 nm, for Compritol® and Precirol®, respectively, and encapsulation efficiency above 85 % for both type of lipids. These LN decrease the hemolytic toxicity of the drug by 90 %. Pharmacokinetic and biodistribution profiles of the drug were studied after intravenous and oral administration of edelfosine-containing LN, providing an increase in relative oral bioavailability of 1500 % after a single oral administration of drug-loaded LN, maintaining edelfosine plasma levels over 7 days in contrast to a single oral administration of edelfosine solution, which presents a relative oral bioavailability of 10 %. Moreover, edelfosine-loaded LN showed a high accumulation of the drug in lymph nodes and resulted in slower tumor growth than the free drug in a murine lymphoma xenograft model, as well as potent extranodal dissemination inhibition. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Future Medicine | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Edelfosine | es_ES |
dc.subject | Lipid nanoparticles | es_ES |
dc.subject | Bioavailability | es_ES |
dc.subject | Pharmacokinetics | es_ES |
dc.subject | Biodistribution | es_ES |
dc.subject | Lymphoma | es_ES |
dc.title | Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | http://dx.doi.org/10.2217/nnm.11.134 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.